Development of a Targeted Urine Proteome Assay for kidney diseases.
about
Current state of the art for enhancing urine biomarker discovery.Clinical applications of MS-based protein quantification.Use of a Targeted Urine Proteome Assay (TUPA) to identify protein biomarkers of delayed recovery after kidney transplant.Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics.
P2860
Development of a Targeted Urine Proteome Assay for kidney diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of a Targeted Urine Proteome Assay for kidney diseases.
@en
Development of a Targeted Urine Proteome Assay for kidney diseases.
@nl
type
label
Development of a Targeted Urine Proteome Assay for kidney diseases.
@en
Development of a Targeted Urine Proteome Assay for kidney diseases.
@nl
prefLabel
Development of a Targeted Urine Proteome Assay for kidney diseases.
@en
Development of a Targeted Urine Proteome Assay for kidney diseases.
@nl
P2093
P2860
P356
P1476
Development of a Targeted Urine Proteome Assay for kidney diseases
@en
P2093
Chirag R Parikh
Christopher M Colangelo
Jennifer L Cantley
Justin Belcher
Kathryn L Stone
Lisa Chung
Lloyd G Cantley
Thomas Abbott
P2860
P356
10.1002/PRCA.201500020
P577
2015-10-06T00:00:00Z